NewsSource: EClinCloud

EClinCloud Invites You to Try the Unified Cloud Platform App—So This Is ECC ONE!

2 min readEClinCloud Editorial Team
Article illustration

Source: EClinCloud. Author: EClinCloud.

Article illustration

Ta-da!

EClinCloud Unified Cloud Platform App—ECC ONE

Now across major iOS and Android app stores,

Fully launched!

EClinCloud invites you to try it out!

So This Is ECC ONE

Article illustration
ECC ONE is a mobile application developed on EClinCloud's unified cloud platform. Built around the clinical operations needs of sponsors, CROs, and clinical trial institutions, it provides a mobile collaboration solution for clinical trial projects. Without needing to open a computer, users can complete tasks such as filling out reports, entering data, and approving workflows anytime and anywhere on a mobile phone.
At the same time, it enables more portable and real-time mobile management of clinical trials through features such as a unified access portal, project visualization, and monitoring calendar reminders. Using AI technology, it enables intelligent document QC and automated filing, making document processing more efficient and significantly saving time and effort.


Article illustration
ECC ONE integrates multiple clinical trial SaaS applications—CTMS, eTMF, and RM—under a unified login portal spanning the entire clinical trial lifecycle. With interconnected data across applications, it supports key stages of clinical trials and enables online multi-party collaboration through close coordination and resource integration.

Through mobile access, online workflows, data sharing, and timely multi-dimensional analysis and presentation, ECC ONE delivers more real-time dynamic information visibility for clinical trial projects, improves clinical trial execution efficiency and management quality, reduces clinical research costs, lowers risk, and effectively shortens R&D timelines.

ECC ONE Features

Article illustration
Article illustration

Article illustration


App Download

Article illustration



About EClinCloud

EClinCloud is a technology company focused on clinical R&D. It provides an integrated, interconnected unified cloud platform for clinical trials (including eCOA, CTMS, eTMF, EDC, RTSM, and RM, as well as solutions within these and other technology products and offerings such as scale design, scale copyright management, linguistic validation, rater training, and data quality analysis) and clinical trial endpoint assessment technologies across therapeutic areas (including central nervous system and ophthalmology). By combining cutting-edge technology with life sciences data, EClinCloud builds a globally leading "patient-centric" SaaS cloud platform supporting clinical evidence to help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.




Article illustration

Read the original WeChat article

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.